Interview with venture case winner Alterniity: We didn't fly too high or too low”
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas (@ITarnanas) / Twitter
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Ioannis Tarnanas - Worldwebforum
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia: 9781466682344: Medicine & Health Science Books @ Amazon.com
Ioannis Tarnanas - Worldwebforum
Greek Researcher Receives Top European Innovation Award
TGL2019 - Dr. Ioannis Tarnanas - YouTube
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ιωάννης Ταρνανάς | Cretalive
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
Greek Researcher Receives Top European Innovation Award (video)
Ioannis Tarnanas - Worldwebforum
